Literature DB >> 19361745

The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.

Marta Palomo1, Maribel Diaz-Ricart, Carla Carbo, Montserrat Rovira, Francesc Fernandez-Aviles, Gines Escolar, Günther Eissner, Ernst Holler, Enric Carreras.   

Abstract

This study evaluated the relative impact of the intensity of the conditioning regimen and the alloreactivity in the endothelial dysfunction occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT). It involved a comparative analysis of the effect of incubating human umbilical vein endothelial cells (ECs) with serum samples from patients receiving autologous HSCT (auto-HSCT) or unrelated donor allo-HSCT. In both groups, blood samples were collected through a central line before conditioning (Pre), before transplantation (day 0), and at days 7, 14, and 21 after transplantation. Changes in the expression of EC receptors and adhesion proteins, adhesion of leukocytes and platelets under flow, and signaling pathways were analyzed. Endothelial activation and damage were observed in both groups, but with differing patterns. All markers of endothelial dysfunction demonstrated a progressive increase from day Pre to day 14 in the auto-HSCT group and exhibited 2 peaks of maximal expression (at days 0 and 21) in the allo-HSCT group. Both treatments induced a proinflammatory state (ie, expression of adhesion receptors, leukocyte adhesion, and p38 MAPK activation) and cell proliferation (ie, morphology and activation of ErK42/44). Prothrombotic changes (ie, von Willebrand factor expression and platelet adhesion) predominated after allo-HSCT, and a proapoptotic tendency (ie, activation of SAPK/JNK) was seen only in this group. These findings indicate that endothelial activation and damage after HSCT also occur in the autologous setting and affect macrovascular ECs. After the initial damage induced by the conditioning regimen, other factors, such as granulocyte colony-stimulating factor (G-CSF) toxicity, engraftment, and alloreactivity, may contribute to the endothelial damage seen during HSCT. Further studies are needed to explore the association between this endothelial damage and the vascular complications associated with HSCT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361745     DOI: 10.1016/j.bbmt.2009.01.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  22 in total

1.  What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance.

Authors:  Marta Palomo; Enrique Mir; Montse Rovira; Ginés Escolar; Enric Carreras; Maribel Diaz-Ricart
Journal:  Blood       Date:  2016-01-11       Impact factor: 22.113

2.  The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium.

Authors:  Julia Martinez-Sanchez; Marta Palomo; Sergi Torramade-Moix; Ana Belen Moreno-Castaño; Montserrat Rovira; Gonzalo Gutiérrez-García; Francesc Fernández-Avilés; Gines Escolar; Olaf Penack; Laura Rosiñol; Enric Carreras; Maribel Diaz-Ricart
Journal:  Bone Marrow Transplant       Date:  2020-05-13       Impact factor: 5.483

Review 3.  Translational research efforts in biomarkers and biology of early transplant-related complications.

Authors:  Sophie Paczesny; Maribel Diaz-Ricart; Enric Carreras; Enrique Carerras; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2011-01       Impact factor: 5.742

4.  Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.

Authors:  Carlos Rondon-Clavo; Michael Scordo; Patrick Hilden; Gunjan L Shah; Christina Cho; Molly A Maloy; Esperanza B Papadopoulos; Ann A Jakubowski; Richard J O'Reilly; Boglarka Gyurkocza; Hugo Castro-Malaspina; Roni Tamari; Brian C Shaffer; Miguel-Angel Perales; Edgar A Jaimes; Sergio A Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-26       Impact factor: 5.742

5.  Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease.

Authors:  Jianfeng Yao; Axia Song; Wenbin Cao; Shulian Chen; Lukun Zhou; Shannan Cao; Peng Liu; Mei Wang; Yuanfu Xu; Aiming Pang; Sizhou Feng; Mingzhe Han
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

6.  Endothelial damage is aggravated in acute GvHD and could predict its development.

Authors:  E Mir; M Palomo; M Rovira; A Pereira; G Escolar; O Penack; E Holler; E Carreras; M Diaz-Ricart
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

Review 7.  Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.

Authors:  Gillian M Keating
Journal:  Clin Drug Investig       Date:  2014-12       Impact factor: 2.859

Review 8.  Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.

Authors:  H Joachim Deeg; Emily Spaulding; Howard M Shulman
Journal:  Leuk Lymphoma       Date:  2009-10

Review 9.  Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

Authors:  Pedro Castro; Marta Palomo; Ana Belen Moreno-Castaño; Sara Fernández; Sergi Torramadé-Moix; Georgina Pascual; Julia Martinez-Sanchez; Edward Richardson; Adrián Téllez; Josep M Nicolas; Enric Carreras; Paul G Richardson; Juan José Badimon; Gines Escolar; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-07       Impact factor: 3.947

Review 10.  Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.

Authors:  Thomas Luft; Peter Dreger; Aleksandar Radujkovic
Journal:  Bone Marrow Transplant       Date:  2021-07-12       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.